Physician profile
Jared B Kevern
NPI 1871029652
$712.71
in general payments reported to CMS, 2019-2025
13 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.33 · 2022: $98.73 · 2023: $162 · 2024: $192 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $289.11 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $80.99 | 2025 | Qelbree |
| Pfizer INC. | $76.19 | 2021-2025 | |
| Ironshore Pharmaceuticals INC. | $75.17 | 2023-2024 | Jornay Pm |
| Adlon Therapeutics L.P. | $58.22 | 2021 | |
| Sanofi-Aventis U.S. LLC | $28.93 | 2025 | |
| Tris Pharma INC | $18.71 | 2025 | Onyda Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $16.83 | 2022 | |
| Merck Sharp & Dohme LLC | $15.06 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.99 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $13.81 | 2023 | Pediarix, Rotarix, Bexsero |
| Cranial Technologies, INC | $13.13 | 2024 | Doc Band |
| Kaleo, INC. | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Kevern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.